Blogs

31. How Patient-Centric Approaches Are Shaping The Future Of CGT 8/6/2024

    Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.

32. EMA Adopts Collaborative Approach With ATMP Guideline Update 7/17/2024

    The EMA has taken a collaborative approach with its updated ATMP guideline, aiming to streamline development and clarify regulatory expectations for cell and gene therapies across Europe's landscape.

33. Pre-Launch Checklist - A Roadmap To Success 6/21/2024

    The path from groundbreaking therapy to readily available treatment requires a strategic approach. Delve into ten critical questions that can help you chart a successful course for your CGT therapy.

34. Cell And Gene Therapy (CGT): Pre-Launch Checklist 6/17/2024

    Discover the ten questions to ask yourself and your commercialization partner to chart a comprehensive strategy that aims to support the successful advancement of your therapy.

35. Navigating The Launch Of ATMPs In Europe 5/29/2024

    In 2025, EU's Health Technology Assessment will reshape market access for ATMPs. Proactive planning is crucial for developers to navigate these changes and ensure patient access to innovative therapies.

36. Navigating CGT Commercialization: Key Areas For Success 5/13/2024

    The cutting-edge realm of cell and gene therapy holds immense promise for revolutionizing healthcare, and its successful commercialization hinges on several key factors.

37. Opportunities And Pain Points For CGT Innovation And Market Access 3/11/2024

    Review key insights shared by experts during Advanced Therapies Week 2024 and explore what these mean in the broader context of successfully bringing cell and gene therapies to patients.

38. A Comparative Guide To CGTs: Modalities, Landscape, And Logistics 2/29/2024

    Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy

39. Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions 12/8/2023

    Explore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.

40. Crafting An Effective Commercialization Strategy For CGTs 10/25/2023

    Patient access and manufacturing efficiency persist as barriers to widespread adoption of CGTs. An effective commercialization strategy is crucial to expand access to these life-changing therapies.